Total planned funding: $298,969,826
Clear active filters
Chemonics International
HTXD: Treatment: ARV Drugs
2010
2011
2012
2013
2014
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $82,674,894 |
| Tanzania | $54,139,102 |
| Zambia | $52,771,120 |
| Uganda | $27,359,475 |
| Mozambique | $19,514,206 |
| Zimbabwe | $18,745,558 |
| Democratic Republic of the Congo | $18,342,927 |
| Haiti | $10,733,185 |
| Côte d'Ivoire | $4,129,279 |
| Burundi | $3,438,296 |
| Rwanda | $2,377,257 |
| West Africa Region | $2,012,397 |
| Namibia | $1,075,000 |
| Lesotho | $482,041 |
| Western Hemisphere Region | $309,202 |
| Eswatini | $294,359 |
| Botswana | $250,003 |
| Asia Regional Program | $175,500 |
| Cameroon | $146,025 |
Organizational Types
| Private Contractor | $298,969,826 |
Program Areas
| Treatment | $298,969,826 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $298,969,826 |